BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36613510)

  • 41. Virtual Screening for Biomimetic Anti-Cancer Peptides from
    Chantawannakul J; Chatpattanasiri P; Wattayagorn V; Kongsema M; Noikaew T; Chumnanpuen P
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted Biomimetic Nanoparticles for Synergistic Combination Chemotherapy of Paclitaxel and Doxorubicin.
    Rui M; Xin Y; Li R; Ge Y; Feng C; Xu X
    Mol Pharm; 2017 Jan; 14(1):107-123. PubMed ID: 27982602
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination antitumor effects of micelle-loaded anticancer drugs in a CT-26 murine colorectal carcinoma model.
    Na HS; Lim YK; Jeong YI; Lee HS; Lim YJ; Kang MS; Cho CS; Lee HC
    Int J Pharm; 2010 Jan; 383(1-2):192-200. PubMed ID: 19732817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers.
    Rick FG; Buchholz S; Schally AV; Szalontay L; Krishan A; Datz C; Stadlmayr A; Aigner E; Perez R; Seitz S; Block NL; Hohla F
    Cell Cycle; 2012 Jul; 11(13):2518-25. PubMed ID: 22751419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative analysis of the anti-proliferative activity of combinations of selected iron-chelating agents and clinically used anti-neoplastic drugs.
    Potuckova E; Jansova H; Machacek M; Vavrova A; Haskova P; Tichotova L; Richardson V; Kalinowski DS; Richardson DR; Simunek T
    PLoS One; 2014; 9(2):e88754. PubMed ID: 24586383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways.
    Hwang JT; Ha J; Park OJ
    Biochem Biophys Res Commun; 2005 Jul; 332(2):433-40. PubMed ID: 15896711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells.
    Duarte D; Vale N
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33271968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bevacizumab-enhanced antitumor effect of 5-fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2-specificity protein 1 pathway.
    Liu W; Zhang J; Yao X; Jiang C; Ni P; Cheng L; Liu J; Ni S; Chen Q; Li Q; Zhou K; Wang G; Zhou F
    Cancer Sci; 2018 Oct; 109(10):3294-3304. PubMed ID: 30151975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways.
    Shakibaei M; Mobasheri A; Lueders C; Busch F; Shayan P; Goel A
    PLoS One; 2013; 8(2):e57218. PubMed ID: 23451189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin enhancement of the antitumor activity of chemotherapeutic agents in colorectal cancer is linked with downregulating PIK3CA and GRB2.
    Agrawal S; Woźniak M; Łuc M; Makuch S; Pielka E; Agrawal AK; Wietrzyk J; Banach J; Gamian A; Pizon M; Ziółkowski P
    Sci Rep; 2019 Nov; 9(1):16647. PubMed ID: 31719636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A selective p53 activator and anticancer agent to improve colorectal cancer therapy.
    Ramos H; Soares MIL; Silva J; Raimundo L; Calheiros J; Gomes C; Reis F; Monteiro FA; Nunes C; Reis S; Bosco B; Piazza S; Domingues L; Chlapek P; Vlcek P; Fabian P; Rajado AT; Carvalho ATP; Veselska R; Inga A; Pinho E Melo TMVD; Saraiva L
    Cell Rep; 2021 Apr; 35(2):108982. PubMed ID: 33852837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin.
    Khaledi S; Jafari S; Hamidi S; Molavi O; Davaran S
    J Biomater Sci Polym Ed; 2020 Jun; 31(9):1107-1126. PubMed ID: 32249693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
    Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
    Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
    Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vascular-targeted TNFα improves tumor blood vessel function and enhances antitumor immunity and chemotherapy in colorectal cancer.
    Lu L; Li ZJ; Li LF; Wu WK; Shen J; Zhang L; Chan RL; Yu L; Liu YW; Ren SX; Chan KM; Cho CH
    J Control Release; 2015 Jul; 210():134-46. PubMed ID: 26003042
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potentiation of the anti-proliferative effects of anti-cancer drugs by octreotide in vitro and in vivo.
    Weckbecker G; Raulf F; Tolcsvai L; Bruns C
    Digestion; 1996; 57 Suppl 1():22-8. PubMed ID: 8813462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells.
    Prados J; Melguizo C; Rama AR; Ortiz R; Segura A; Boulaiz H; Vélez C; Caba O; Ramos JL; Aránega A
    Cancer Chemother Pharmacol; 2010 May; 66(1):69-78. PubMed ID: 19771430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F; Duivenvoorden WC; Singh G
    Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?].
    Carnaghi C; Zucali P; Garassino I
    Tumori; 2000; 86(5 Suppl 2):S19-25. PubMed ID: 11195298
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Lin LT; Uen WC; Choong CY; Shi YC; Lee BH; Tai CJ; Tai CJ
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31163662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.